Literature DB >> 22706984

Endoscopic Third Ventriculostomy Success Score (ETVSS) predicting success in a series of 50 pediatric patients. Are the outcomes of our patients predictable?

Laura González García1, Bienvenido Ros López, Guillermo Ibáñez Botella, Miguel Domínguez Páez, Sandra Pérez da Rosa, Francisca Rius, Miguel Angel Arráez Sánchez.   

Abstract

PURPOSE: In our series of endoscopic third ventriculostomy (ETV), we sought to establish the relationship between the preoperative prediction using the Endoscopic Third Ventriculostomy Success Score (ETVSS) and the postsurgical success rate.
MATERIALS AND METHODS: This descriptive analytical study comprised 50 pediatric patients who underwent 58 ETV procedures between 2003 and 2011. Data regarding clinical, surgical, and radiological findings were obtained from a continuously updated database. For each patient, we calculated the ETVSS, based on the patient's age, hydrocephalus etiology, and presence of a previous shunt. We considered success to be an established or improved clinical state and at least one of the following radiological criteria: (a) reduction in ventricular size or stable ventricles with disappearance of periventricular edema and increased subarachnoid space over cerebral convexities, (b) flow artifact in sagittal T2FSE MR, or (c) bidirectional flow signal in 2D-CPC MR. Statistical significance was set at p < 0.05. Six months was the minimum postoperative follow-up required.
RESULTS: The ETV was successful in 29 patients (58 %). Patients aged over 1 year achieved the best results (p < 0.019). For those who underwent successful ETV, the mean ETVSS was 71.03 (95 % CI, 66.23-75.84). In those for whom the ETV was not successful, the mean ETVSS was 60 (95 % CI, 53.09-66.90); (p < 0.007).
CONCLUSIONS: The success of ETV in our series could have been predicted by ETVSS. Predictability could help establish stricter surgical selection criteria, thereby obtaining higher success rates, as well as preparing the patients and their families for expected outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22706984     DOI: 10.1007/s00381-012-1836-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  36 in total

1.  Endoscopic third ventriculostomy for tumor-related hydrocephalus in a pediatric population.

Authors:  Pulak Ray; George I Jallo; R Y H Kim; Bong-Soo Kim; Sean Wilson; Karl Kothbauer; Rick Abbott
Journal:  Neurosurg Focus       Date:  2005-12-15       Impact factor: 4.047

2.  Evaluating the Children's Hospital of Alabama endoscopic third ventriculostomy experience using the Endoscopic Third Ventriculostomy Success Score: an external validation study.

Authors:  Robert P Naftel; Gavin T Reed; Abhaya V Kulkarni; John C Wellons
Journal:  J Neurosurg Pediatr       Date:  2011-11       Impact factor: 2.375

3.  Treatment of hydrocephalus with third ventriculocisternostomy: outcome and CSF flow patterns.

Authors:  L C Goumnerova; D M Frim
Journal:  Pediatr Neurosurg       Date:  1997-09       Impact factor: 1.162

4.  Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score.

Authors:  Abhaya V Kulkarni; James M Drake; John R W Kestle; Conor L Mallucci; Spyros Sgouros; Shlomi Constantini
Journal:  J Neurosurg Pediatr       Date:  2010-10       Impact factor: 2.375

Review 5.  Endoscopic third ventriculostomy in obstructive infantile hydrocephalus: remarks about the so-called 'unsuccessful cases'.

Authors:  Pasquale Gallo; Alexandru Szathmari; Sara De Biasi; Carmine Mottolese
Journal:  Pediatr Neurosurg       Date:  2011-05-03       Impact factor: 1.162

6.  Failure of third ventriculostomy in the treatment of aqueductal stenosis in children.

Authors:  G Cinalli; C Sainte-Rose; P Chumas; M Zerah; F Brunelle; G Lot; A Pierre-Kahn; D Renier
Journal:  J Neurosurg       Date:  1999-03       Impact factor: 5.115

7.  Management of hydrocephalus by endoscopic third ventriculostomy in patients with myelomeningocele.

Authors:  C Teo; R Jones
Journal:  Pediatr Neurosurg       Date:  1996-08       Impact factor: 1.162

8.  Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus.

Authors:  Abhaya V Kulkarni; James M Drake; Conor L Mallucci; Spyros Sgouros; Jonathan Roth; Shlomi Constantini
Journal:  J Pediatr       Date:  2009-05-15       Impact factor: 4.406

9.  Endoscopic third ventriculostomy in infants of less than 1 year of age: which factors influence the outcome?

Authors:  Dorothee Koch; Wolfgang Wagner
Journal:  Childs Nerv Syst       Date:  2004-04-28       Impact factor: 1.475

10.  Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus: an Italian multicenter study.

Authors:  Michelangelo Gangemi; Francesco Maiuri; Michele Naddeo; Umberto Godano; Carmelo Mascari; Giovanni Broggi; Paolo Ferroli
Journal:  Neurosurgery       Date:  2008-07       Impact factor: 4.654

View more
  12 in total

Review 1.  Development and content validation of performance assessments for endoscopic third ventriculostomy.

Authors:  Gerben E Breimer; Faizal A Haji; Eelco W Hoving; James M Drake
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

2.  Neuroendoscopic biopsy: analysis of a series of 80 patients.

Authors:  Ángela Ros-Sanjuán; Bienvenido Ros-López; Guillermo Ibáñez-Botella; Miguel Domínguez-Páez; Antonio Carrasco-Brenes; Miguel Ángel Arráez-Sánchez
Journal:  Neurosurg Rev       Date:  2018-11-07       Impact factor: 3.042

3.  International Infant Hydrocephalus Study: initial results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus.

Authors:  Abhaya V Kulkarni; Spyros Sgouros; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2016-04-23       Impact factor: 1.475

4.  Hydrocephalus in aqueductal stenosis--a retrospective outcome analysis and proposal of subtype classification.

Authors:  Imke Rodis; Cynthia Vanessa Mahr; Michael K Fehrenbach; Jürgen Meixensberger; Andreas Merkenschlager; Matthias K Bernhard; Stefan Schob; Ulrich Thome; Robin Wachowiak; Franz W Hirsch; Ulf Nestler; Matthias Preuss
Journal:  Childs Nerv Syst       Date:  2016-02-27       Impact factor: 1.475

5.  External validation of the ETV success score in 313 pediatric patients: a Brazilian single-center study.

Authors:  Leopoldo Mandic Ferreira Furtado; José Aloysio da Costa Val Filho; Eustaquio Claret Dos Santos Júnior
Journal:  Neurosurg Rev       Date:  2021-01-03       Impact factor: 3.042

6.  An audit of endoscopic third ventriculostomy (ETV) in a regional paediatric neurosurgical centre assessing the accuracy and feasibility of the ETV success score.

Authors:  Stefan Yordanov; M R Garnett; T Santarius; K Holland; I Jalloh; M Jawad Naushahi
Journal:  Acta Neurochir (Wien)       Date:  2022-02-25       Impact factor: 2.216

7.  Endoscopic third ventriculostomy: can we predict success during surgery?

Authors:  L Romero; B Ros; G Ibáñez; F Ríus; L González; Ma Arráez
Journal:  Neurosurg Rev       Date:  2013-08-30       Impact factor: 3.042

8.  Visual outcome after endoscopic third ventriculostomy for hydrocephalus.

Authors:  Ji-Ho Jung; Yong-Hyun Chai; Shin Jung; In-Young Kim; Woo-Youl Jang; Kyung-Sub Moon; Seul-Kee Kim; Sangjoon Chong; Seung-Ki Kim; Tae-Young Jung
Journal:  Childs Nerv Syst       Date:  2017-11-03       Impact factor: 1.475

9.  An external validation of the ETVSS for both short-term and long-term predictive adequacy in 104 pediatric patients.

Authors:  G E Breimer; D A Sival; M G J Brusse-Keizer; E W Hoving
Journal:  Childs Nerv Syst       Date:  2013-05-05       Impact factor: 1.475

Review 10.  Endoscopic third ventriculostomy with/without choroid plexus cauterization for hydrocephalus due to hemorrhage, infection, Dandy-Walker malformation, and neural tube defect: a meta-analysis.

Authors:  Anthony Zandian; Matthew Haffner; James Johnson; Curtis J Rozzelle; R Shane Tubbs; Marios Loukas
Journal:  Childs Nerv Syst       Date:  2013-12-28       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.